|
Mould surveillance at a tertiary university hospital documents increasing azole resistance in Aspergillus among Danish cystic fibrosis patients |
17-Aug |
|
|
|
Evaluation of the LD Bio Aspergillus ICT lateral flow assay as a point-of-care test for serological antibody detection in chronic pulmonary aspergillosis |
17-Aug |
|
|
|
Adherence to guidelines and related mortality when using antifungal drugs for invasive aspergillosis in patients with haematologic malignancies and/or stem cell transplantation |
17-Aug |
|
|
|
Cerebral Aspergillosis Lesional Study (CEREALS): a multi-centre retrospective French study |
17-Aug |
|
|
|
In vivo pharmacodynamic evaluation of the novel antifungal agent APX001 in a murine model of invasive pulmonary aspergillosis against wild-type and Cyp51 mutant Aspergillus fumigatus strains |
17-Aug |
|
|
|
Improved serological diagnosis of chronic pulmonary aspergillosis in ImmunoCAP IgG-negative patients using the LD Bio Aspergillus ICT lateral flow assay |
17-Aug |
|
|
|
Standardisation and application of simple and low cost tetra primer ARMS-PCR for detection of TR34/L98H mutation in triazole resistant Aspergillus fumigatus |
17-Aug |
|
|
|
Diagnostic characteristics of the recently commercialised OLM AspLFD lateral flow device in haematology patients: a multi-centre study |
17-Aug |
|
|
|
Analysis of the microbiome and mycobiome in chronic fungal rhinosinusitis |
17-Aug |
|
|
|
Isavuconazole kinetic exploration for clinical practice |
17-Aug |
|
|
